Follow-up comparison Pharmacokinetics study for ND0701

Trial Profile

Follow-up comparison Pharmacokinetics study for ND0701

Planning
Phase of Trial: Phase I

Latest Information Update: 30 Mar 2017

At a glance

  • Drugs Apomorphine (Primary)
  • Indications Parkinson's disease
  • Focus Adverse reactions
  • Most Recent Events

    • 30 Mar 2017 According to a NeuroDerm media release, this trial is expected to initiate in the second half of 2017.
    • 08 Dec 2016 New trial record
    • 02 Dec 2016 According to a NeuroDerm media release, this trial is expected to initiate in the first half of 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top